President Donald Trump is considering or planning to fire U.S. Food and Drug Administration Commissioner Dr. Marty Makary [1, 2, 3].

The potential removal of the FDA chief signals a possible shift in how the administration handles critical public health mandates and drug approvals. Because the FDA oversees the safety of the nation's food and medicine supply, a change in leadership can alter the trajectory of medical authorizations and regulatory enforcement.

Reports indicate the president is weighing the move after simmering frustration with the performance of the agency head [2]. According to a White House source, Makary is expected to leave the commissioner role after a tumultuous year [4].

Sources cite several points of contention contributing to the friction. These include clashes over the handling of the abortion pill, vaccines, and general drug approvals [5]. Additionally, there has been pressure regarding the authorization of flavored vapes [4].

"President Donald Trump is planning to fire U.S. Food and Drug Administration Commissioner Marty Makary," Reuters said [1].

The agency is headquartered in Washington, D.C., where it manages the intersection of science and federal law. The decision to remove a commissioner often stems from a misalignment between the president's policy goals and the agency's regulatory execution.

While some reports state Trump is currently considering the move, others suggest the president has already signed off on the ousting [5]. The administration has not issued a formal public statement regarding the timing of a potential departure.

President Donald Trump is planning to fire U.S. Food and Drug Administration Commissioner Marty Makary.

The potential removal of Dr. Makary suggests a deepening divide between the White House and the FDA's current regulatory approach. By focusing on disagreements over vaccines, abortion pills, and flavored vapes, the administration may be seeking a leader more aligned with specific political priorities regarding personal liberties and pharmaceutical deregulation.